Status:
ENROLLING_BY_INVITATION
AI-Powered Artificial Vision for Visual Prostheses
Lead Sponsor:
University of California, Santa Barbara
Collaborating Sponsors:
Universidad Miguel Hernandez de Elche
Conditions:
Blindness, Acquired
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Visual impairment is one of the ten most prevalent causes of disability and poses extraordinary challenges to individuals in our society that relies heavily on sight. Living with acquired blindness no...
Detailed Description
The investigators will perform basic experimental studies involving humans (BESH) designed to quantify the perceptual experiences of visual prosthesis patients. These experiments will follow standard ...
Eligibility Criteria
Inclusion
- Criteria for inclusion of visual prosthesis users:
- Subject must be at least 18 years of age;
- Subject has been implanted with a visual prosthesis (e.g., Argus II, Orion, Cortivis)
- Subject has healed from surgery and the surgeon has cleared the subject for programming;
- Subject has the cognitive and communication ability to participate in the study (i.e., follow spoken directions, perform tests, and give feedback);
- Subject is willing to conduct psychophysics testing up to 4-6 hours per day of testing on 3-5 consecutive days;
- Subject is capable of understanding patient information materials and giving written informed consent;
- Subject is able to walk unassisted.
- Criteria for inclusion of sighted control subjects:
- Subject speaks English;
- Subject must be at least 18 years of age;
- Subject has visual acuity of 20/40 or better (corrected);
- Subject has the cognitive and communication ability to participate in the study (i.e., follow spoken directions, perform tests, and give feedback);
- Subject is capable of understanding participant information materials and giving written informed consent.
- Subject is able to walk unassisted
- Exclusion criteria:
- Visual prosthesis users: Subject is unwilling or unable to travel to testing facility for at least 3 days of testing within a one-week timeframe;
- Sighted controls: Subject has a history of motion sickness or flicker vertigo
- All: Subject has language or hearing impairment
Exclusion
Key Trial Info
Start Date :
October 2 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2027
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT06117332
Start Date
October 2 2023
End Date
August 31 2027
Last Update
July 31 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, Santa Barbara
Santa Barbara, California, United States, 93106
2
University Miguel Hernandez
Elche, Alicante, Spain, 03202